Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer: short-term results
- PMID: 19574204
- DOI: 10.1007/s12094-009-0385-z
Initial surgical experience in laparoscopic total mesorectal excision for middle and lower third rectal cancer: short-term results
Abstract
Introduction: Total mesorectal excision (TME) of the rectum has been advocated as the gold standard surgical treatment of middle and lower third rectal cancer. Laparoscopy has gained acceptance among surgeons in the treatment of colon malignancies, while scepticism exists about laparoscopic TME in terms of safety and its oncological adequacy.
Objective: To evaluate the impact of laparoscopic TME on surgical and oncological outcome in a group of consecutive unselected patients.
Methods: One hundred and thirty-two patients with middle or inferior rectal cancer were admitted to our unit and underwent TME from December 1998 to February 2008. Eighty-nine patients were approached with laparoscopy. Patients staged cT3/4 cTxN+ or uTxN+ were submitted to neoadjuvant treatment. Postoperative complications and oncological outcomes were registered.
Results: In the laparoscopic group 80 anterior resections (including 4 intersphincteric resections and manual colo- anal anastomosis) and 9 abdominal-perineal resections were performed. 33.3% of patients were enrolled in "long-course" neoadjuvant chemo-radiotherapy (partial and complete response rates 88.2% and 11.8%, respectively). Protective lateral ileostomy was performed in 72% of patients. Mean operative time was 254.3+/-38.3 min and mean blood loss was 215+/-180 ml. Conversion rate was 12.7%. Morbidity rate was 39.3% without mortality. The rate of anastomotic leaks was 13.48%, reoperation rate 13.48%, recovery rate 3.1+/-1.4 days and hospital stay 10.4+/-4.6 days. Concerning adequacy of oncologic resection, mean distance of the tumour from the anal verge was 4.3+/-2.2 cm. Nodal sampling of 12.4+/-4.8 were obtained. Six patients (6/89, 6.74%) had a R1 margin: 3 distal and 3 circumferential. Median follow-up was 29 months and local recurrence rate was 5.79%. Four-year cumulative overall survival was 78% and disease-free survival was 63% (Kaplan-Meier method).
Conclusions: Laparoscopic approach for rectal tumour is a technically demanding procedure, but it is oncologically safe.
Similar articles
-
Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases.Surg Oncol. 2007 Dec;16 Suppl 1:S113-6. doi: 10.1016/j.suronc.2007.10.035. Epub 2007 Nov 28. Surg Oncol. 2007. PMID: 18054221
-
Video. Advantages of the laparoscopic approach for intersphincteric resection.Surg Endosc. 2011 May;25(5):1661-3. doi: 10.1007/s00464-010-1451-x. Epub 2010 Dec 4. Surg Endosc. 2011. PMID: 21132330
-
Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.Ann Surg Oncol. 2012 Jan;19(1):154-5. doi: 10.1245/s10434-011-1952-4. Epub 2011 Aug 6. Ann Surg Oncol. 2012. PMID: 21822556
-
Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.Surg Endosc. 2004 Feb;18(2):281-9. doi: 10.1007/s00464-002-8877-8. Epub 2003 Dec 29. Surg Endosc. 2004. PMID: 14691716 Review.
-
Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.Br J Surg. 2017 Nov;104(12):1609-1619. doi: 10.1002/bjs.10664. Br J Surg. 2017. PMID: 29044484 Review.
Cited by
-
Influence of conversion on the perioperative and oncologic outcomes of laparoscopic resection for rectal cancer compared with primarily open resection.Surg Endosc. 2013 Dec;27(12):4675-83. doi: 10.1007/s00464-013-3108-z. Epub 2013 Aug 13. Surg Endosc. 2013. PMID: 23943120
-
Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis.PLoS One. 2023 Nov 20;18(11):e0294510. doi: 10.1371/journal.pone.0294510. eCollection 2023. PLoS One. 2023. PMID: 37983236 Free PMC article.